CNBC Television FDA advisory panel votes in favor of adult RSV vaccine from GSK PLC
🎯 Загружено автоматически через бота:
🚫 Оригинал видео:
📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал.
✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его.
📃 Оригинальное описание:
CNBC’s Meg Tirrell joins ’Power Lunch’ to discuss GSK PLC’s RSV vaccine receiving FDA support, ongoing questions around the drug’s approval and the timeline for the drug to be available for children.
1 view
9
3
2 days ago 00:01:20 1
[CNBC Television] BlackRock CEO Larry Fink says bitcoin impacts the U.S. dollar
2 days ago 00:01:39 1
[CNBC Television] Moderna’s phase three RSV trial found to be 83.7% effective in older adults
2 days ago 00:03:43 1
[CNBC Television] We could be approaching an earnings recession: Investment strategist
2 days ago 00:04:09 1
[CNBC Television] Blackstone enters deal to manage AIG’s insurance and housing assets
2 days ago 00:03:07 1
[CNBC Television] Two strategists break down markets ahead of busy earnings week, FOMC meeting
2 days ago 00:01:49 1
[CNBC Television] Small businesses push back on Amazon Prime Day
2 days ago 00:19:11 1
[CNBC Television] ETF Edge, November 11, 2024
2 days ago 00:01:29 1
[CNBC Television] Popular American SUVs to be hit by Mexico tariffs
2 days ago 00:03:48 1
[CNBC Television] Inflation battle is ’absolutely’ done, says Yardeni Research president
2 days ago 00:01:48 1
[CNBC Television] Final Trades: Apple, Oracle, Roku & more
2 days ago 00:01:19 1
[CNBC Television] CNBC Millionaire Survey: 42% expect the economy to be weaker in 2024
2 days ago 00:05:14 1
[CNBC Television] Look for companies with better balance sheets: Pro
2 days ago 00:06:13 1
[CNBC Television] Cyclicals are going to be a winner: Jonathan Golub